GMI-1359

DB18092Investigational

GMI-1359 is a small molecule, glycomimetic compound with dual inhibitory activity against E-selectin and CXCR4.

Mechanism: Pharmacologically active on C-X-C chemokine receptor type 4 and E-selectin
Curator reviewed
Code names: GMI-1359

Resolves to

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with GMI-1359, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.